Search Results

Pharmacokinetic-pharmacodynamic model to predict drug concentrations and intraocular pressure lowering effect for a bimatoprost six-month slow-release system.

• Authors : Kompella R; 296027Cherry Creek High School, Greenwood Village, CO, USA.; Patil M

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2022 Nov 17, pp. 11206721221135910. Date of Electronic Publication: 2022 Nov 17.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Granulomatous uveitis and choroidal detachment in a patient after topical treatment with Bimatoprost: A case report.

• Authors : Massimo L; Unit of Ophthalmology, 'F. Miulli' Hospital, Acquaviva delle Fonti (BA), Italy.; Micelli Ferrari L

Subjects: Choroidal Effusions* ; Glaucoma*/Glaucoma*/Glaucoma*/chemically induced ; Glaucoma*/Glaucoma*/Glaucoma*/drug therapy

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2022 May; Vol. 32 (3), pp. NP19-NP22. Date of Electronic Publication: 2021 Jan 28.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Comparative analysis of ocular redness score evaluated automatically in glaucoma patients under different topical medications.

• Authors : Giannaccare G; Department of Ophthalmology, University Magna Græcia of Catanzaro, Catanzaro, Italy.; Pellegrini M

Subjects: Glaucoma*/Glaucoma*/Glaucoma*/drug therapy ; Ocular Hypertension*/Ocular Hypertension*/Ocular Hypertension*/drug therapy ; Prostaglandins F, Synthetic*

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2021 Sep; Vol. 31 (5), pp. 2405-2411. Date of Electronic Publication: 2020 Nov 04.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Comparison of preserved bimatoprost 0.01% with preservative-free tafluprost: A randomised, investigator-masked, 3-month crossover, multicentre trial, SPORT II.

• Authors : Lemmens S; Department of Ophthalmology, University Hospitals UZ Leuven, Leuven, Belgium.; Department of Neurosciences, Laboratory of Ophthalmology, KU Leuven, Leuven, Belgium.

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2021 Apr 05, pp. 11206721211006573. Date of Electronic Publication: 2021 Apr 05.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Prostaglandin analogue-induced pigmentation of the skin of the nasal septum and nasal alae in a glaucoma patient.

• Authors : Holló G; Department of Ophthalmology, Semmelweis University, Budapest - Hungary.; Kóthy P

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*adverse effects ; Eyelid Diseases/Eyelid Diseases/Eyelid Diseases/*chemically induced ; Glaucoma, Open-Angle/Glaucoma, Open-Angle/Glaucoma, Open-Angle/*drug therapy

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2015 May 25; Vol. 25 (4), pp. e38-9. Date of Electronic Publication: 2015 May 25.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Meta-analysis of randomized controlled trials comparing latanoprost with other glaucoma medications in chronic angle-closure glaucoma.

• Authors : Li J; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou - People's Republic of China.; Lin X

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Glaucoma, Angle-Closure/Glaucoma, Angle-Closure/Glaucoma, Angle-Closure/*drug therapy ; Prostaglandins F, Synthetic/Prostaglandins F, Synthetic/Prostaglandins F, Synthetic/*therapeutic use

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2015 Jan-Feb; Vol. 25 (1), pp. 18-26. Date of Electronic Publication: 2014 Jul 08.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network.

• Authors : Loftus J; Pfizer Ltd, Walton Oaks, London, UK. ; Christopoulou D

Subjects: Practice Patterns, Physicians'*; Amides/Amides/Amides/*administration & dosage ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2012 May-Jun; Vol. 22 (3), pp. 376-87.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print Cited Medium: Internet ISSN: 1724-6016

Record details

Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials.

• Authors : Aptel F; Department of Ophthalmology, Edouard Herriot Hospital, Lyon, France. ; Cucherat M

Subjects: Amides/Amides/Amides/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Cloprostenol/Cloprostenol/Cloprostenol/*analogs & derivatives

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2012 Jan-Feb; Vol. 22 (1), pp. 5-18.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print Cited Medium: Internet ISSN: 1724-6016

Record details

Prostaglandin-timolol fixed combinations efficacy: myth or reality?

• Authors : Konstas AG; Haidich AB; Rossetti L

Subjects: Amides/Amides/Amides/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Cloprostenol/Cloprostenol/Cloprostenol/*analogs & derivatives

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2012 Jan-Feb; Vol. 22 (1), pp. 1-4.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print Cited Medium: Internet ISSN: 1724-6016

Record details

Does the fixed combination of bimatoprost/timolol really produce a better benefit/risk balance than the fixed combination of latanoprost/timolol?

• Authors : Soto J; Diaz S

Subjects: Amides/Amides/Amides/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Cloprostenol/Cloprostenol/Cloprostenol/*analogs & derivatives

• Source: European journal of ophthalmology [Eur J Ophthalmol] 2010 Jan-Feb; Vol. 20 (1), pp. 246-7; author reply 247-8.Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9110772 Publication Model: Print Cited Medium: Print ISSN: 1120-6721

Record details